IT1299069B1 - Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps") - Google Patents

Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")

Info

Publication number
IT1299069B1
IT1299069B1 IT98MI000774A ITMI980774A IT1299069B1 IT 1299069 B1 IT1299069 B1 IT 1299069B1 IT 98MI000774 A IT98MI000774 A IT 98MI000774A IT MI980774 A ITMI980774 A IT MI980774A IT 1299069 B1 IT1299069 B1 IT 1299069B1
Authority
IT
Italy
Prior art keywords
pain syndrome
regional pain
chronic regional
crps
treatment
Prior art date
Application number
IT98MI000774A
Other languages
English (en)
Inventor
Massimo Spriano
Menotti Calvani
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT98MI000774A priority Critical patent/IT1299069B1/it
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to DK99916036T priority patent/DK0994703T3/da
Priority to CA002292638A priority patent/CA2292638C/en
Priority to KR1019997011697A priority patent/KR100573010B1/ko
Priority to AT99916036T priority patent/ATE244566T1/de
Priority to NZ501416A priority patent/NZ501416A/en
Priority to IL133141A priority patent/IL133141A/en
Priority to EP99916036A priority patent/EP0994703B1/en
Priority to ES99916036T priority patent/ES2203115T3/es
Priority to PT99916036T priority patent/PT994703E/pt
Priority to SI9930359T priority patent/SI0994703T1/xx
Priority to AU34426/99A priority patent/AU742013B2/en
Priority to JP55145199A priority patent/JP4482163B2/ja
Priority to BR9906350-6A priority patent/BR9906350A/pt
Priority to PCT/IT1999/000084 priority patent/WO1999052517A2/en
Priority to DE69909395T priority patent/DE69909395T2/de
Publication of ITMI980774A1 publication Critical patent/ITMI980774A1/it
Priority to US09/458,966 priority patent/US6214884B1/en
Application granted granted Critical
Publication of IT1299069B1 publication Critical patent/IT1299069B1/it
Priority to HK00103475A priority patent/HK1026608A1/xx
Priority to US10/423,971 priority patent/US20040209906A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
IT98MI000774A 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps") IT1299069B1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")
JP55145199A JP4482163B2 (ja) 1998-04-10 1999-04-08 ケタンセリンとｌ−カルニチン又はアルカノイルｌ−カルニチンを含むｃｒｐｓの治療のための組成物
KR1019997011697A KR100573010B1 (ko) 1998-04-10 1999-04-08 케탄제린 및 ｌ-카르니틴 또는 알카노일 ｌ-카르니틴을함유하는 ｃｒｐｓ 치료용 조성물
AT99916036T ATE244566T1 (de) 1998-04-10 1999-04-08 Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
NZ501416A NZ501416A (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS
IL133141A IL133141A (en) 1998-04-10 1999-04-08 A composition containing catechins and L-carnitine for the treatment of CRPS
EP99916036A EP0994703B1 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine for the treatment of crps
ES99916036T ES2203115T3 (es) 1998-04-10 1999-04-08 Composicion que comprende ketanserina y l-carnitina para el tratamiento del sindrome de dolor local cronico.
DK99916036T DK0994703T3 (da) 1998-04-10 1999-04-08 Sammensætning omfattende ketanserin og L-carnitin til behandlingen af CRPS
SI9930359T SI0994703T1 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine for the treatment of crps
AU34426/99A AU742013B2 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS
CA002292638A CA2292638C (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps
BR9906350-6A BR9906350A (pt) 1998-04-10 1999-04-08 Composição contendo cetanserina e l-carnitina ou uma alcanoil l-carnitina para o tratamento de crps
PCT/IT1999/000084 WO1999052517A2 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps
DE69909395T DE69909395T2 (de) 1998-04-10 1999-04-08 Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
PT99916036T PT994703E (pt) 1998-04-10 1999-04-08 Composicao compreendendo ketanserina e l-carnitina para o tratamento de sdrc
US09/458,966 US6214884B1 (en) 1998-04-10 1999-12-10 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS
HK00103475A HK1026608A1 (en) 1998-04-10 2000-06-08 Composition comprising ketanserin and l-carnitine for the treatment of crps
US10/423,971 US20040209906A1 (en) 1998-04-10 2003-04-28 Composition comprising ketanserin AND AN ALKANOYL L-CARNITINE FOR THE TREATMENT OF CRPS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")

Publications (2)

Publication Number Publication Date
ITMI980774A1 ITMI980774A1 (it) 1999-10-10
IT1299069B1 true IT1299069B1 (it) 2000-02-07

Family

ID=11379743

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")

Country Status (17)

Country Link
US (2) US6214884B1 (it)
EP (1) EP0994703B1 (it)
JP (1) JP4482163B2 (it)
KR (1) KR100573010B1 (it)
AT (1) ATE244566T1 (it)
AU (1) AU742013B2 (it)
BR (1) BR9906350A (it)
CA (1) CA2292638C (it)
DE (1) DE69909395T2 (it)
DK (1) DK0994703T3 (it)
ES (1) ES2203115T3 (it)
HK (1) HK1026608A1 (it)
IL (1) IL133141A (it)
IT (1) IT1299069B1 (it)
NZ (1) NZ501416A (it)
PT (1) PT994703E (it)
WO (1) WO1999052517A2 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN1686139B (zh) * 2005-04-30 2012-07-11 福建师范大学 酮色林在治疗炎性疼痛的新型镇痛药中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism

Also Published As

Publication number Publication date
US6214884B1 (en) 2001-04-10
AU3442699A (en) 1999-11-01
BR9906350A (pt) 2000-09-19
EP0994703B1 (en) 2003-07-09
JP4482163B2 (ja) 2010-06-16
WO1999052517A2 (en) 1999-10-21
US20040209906A1 (en) 2004-10-21
CA2292638C (en) 2008-08-26
IL133141A (en) 2006-06-11
DE69909395T2 (de) 2004-06-09
ES2203115T3 (es) 2004-04-01
AU742013B2 (en) 2001-12-13
KR20010013685A (ko) 2001-02-26
EP0994703A2 (en) 2000-04-26
ATE244566T1 (de) 2003-07-15
NZ501416A (en) 2002-03-01
CA2292638A1 (en) 1999-10-21
ITMI980774A1 (it) 1999-10-10
KR100573010B1 (ko) 2006-04-24
HK1026608A1 (en) 2000-12-22
DE69909395D1 (de) 2003-08-14
PT994703E (pt) 2003-11-28
WO1999052517A3 (en) 2000-01-06
IL133141A0 (en) 2001-03-19
DK0994703T3 (da) 2003-11-03
JP2002504934A (ja) 2002-02-12

Similar Documents

Publication Publication Date Title
MY119403A (en) Novel compounds with analgesic effect.
MY132705A (en) Novel compounds with analgesic effect
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
NO20053104D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
PL322174A1 (en) Oral pharmaceutic administration forms containing the protonic pump inhibitor and nlpz
HK1056681A1 (en) Gabapentin analogues for sleep disorders
ITMI962356A0 (it) Uso di composti derivati da molecole ad attivita' antinfiammatoria di tipo non steroideo per la prevenzione e il trattamento di
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
SE9802208D0 (sv) Novel compounds
IT1283951B1 (it) Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
GR3015431T3 (en) Use of acetyl L-carnitine in the therapeutic treatment of coma.
BG102342A (en) Optical active derivative of phenylpyrimidine as an anlgesics
IT1299069B1 (it) Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")
HK1028546A1 (en) Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
SE9802209D0 (sv) Novel compounds
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
ITRM950544A0 (it) Uso della l-carnitina di suoi derivati e di loro sali farmaceuticamen-te accettabili in combinazione con farmaci antiretrovirali per ridurrei livelli di ceramide e potenziare l'attivita' di tali farmaci antire-trovirali per il trattamento terapeutico dell'invenzione...
IL127851A0 (en) Inhibition of TNF activity
IT1265342B1 (it) Composizioni farmaceutiche a base di derivati della glicina
MX9701294A (es) Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora.
NO20010984L (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4-fluorfenyl)etyl]-4-piperidinmetanol for behandling av sovnforstyrrelser
ITRM980701A0 (it) Uso della l-carnitina e dei suoi alcanoil derivati per la preparazione di un medicamento avente attivita' antitumorale
MX9804798A (es) Nuevos compuestos con efecto analgesico.
MX9804797A (es) Nuevos compuestos con efecto analgesico.
IT1263076B (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.

Legal Events

Date Code Title Description
0001 Granted